Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims
Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims
复制标题
西班牙裔长期结直肠癌幸存者的肺炎球菌疫苗接种情况：索赔的横断面评估
DOI：
10.2196/12603
复制
发表时间：
2019
影响因子：
8.5
通讯作者：
M. Schiaffino
中科院分区：
文献类型：
--
作者：
Ryan J Moran;J. Waalen;James D. Murphy;V. Nalawade;M. Schiaffino
背景结直肠癌（CRC）是美国第二大癌症相关死亡原因。然而，存活率一直在增加。癌症幸存者和服务不足的人群都面临着独特的健康相关挑战和差异，这些挑战和差异可能存在于长期结直肠癌幸存者中，因为这与常规预防护理有关，特别是肺炎球菌 (PNM) 疫苗接种。目的 本研究的目的是探讨西班牙裔医疗保险接受者与非西班牙裔人群相比，长期 CRC 存活率与接受 PNM 疫苗之间的关系。方法 本研究是对监测、流行病学和最终结果 (SEER)-医疗保险索赔数据的横断面分析，检查长期 CRC 幸存者中接受 PNM 疫苗接种的种族差异。多变量逻辑回归模型考虑了西班牙裔种族，同时控制了社会人口学特征、合并症评分、年龄、肿瘤分期和 SEER 登记。结果 我们的样本显示 32,501 名长期 CRC 幸存者，根据既定的 SEER 算法，其中 1509 名被识别为西班牙裔 (4.64%)。总共有 16,252 名 CRC 幸存者（占我们样本的 50.00%）接受了 PNM 疫苗接种。我们发现，与非西班牙裔幸存者相比，西班牙裔 CRC 幸存者接种 PNM 疫苗的几率降低了 10% (P=.03)。结论 长期 CRC 幸存者在使用 PNM 疫苗接种方面可能存在差异。在 Medicare 受益人中，有关 PNM 疫苗接种的索赔数据的使用突显了指南指导的预防性护理的利用率相对较低。
Background Colorectal cancer (CRC) is the second leading cancer-related cause of death in the United States. However, survivorship has been increasing. Both cancer survivors and underserved populations experience unique health-related challenges and disparities that may exist among long-term CRC survivors as it relates to routine preventive care, specifically pneumococcal (PNM) vaccination. Objective The aim of this study was to explore the relationship between long-term CRC survival and the receipt of PNM vaccine among Hispanic Medicare recipients compared with non-Hispanic populations. Methods This study is a cross-sectional analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare claims data examining ethnic differences in the receipt of PNM vaccination among long-term CRC survivors. Multivariable logistic regression models considered Hispanic ethnicity while controlling for sociodemographic characteristics, comorbidity score, age, tumor stage, and SEER registry. Results Our sample revealed 32,501 long-term CRC survivors, and 1509 identified as Hispanic (4.64%) based on an established SEER algorithm. In total, 16,252 CRC survivors, or 50.00% of our sample, received a PNM vaccination. We found that Hispanic CRC survivors had 10% decreased odds of having received a PNM vaccine compared with non-Hispanic survivors (P=.03). Conclusions Disparities likely exist in the utilization of PNM vaccination among long-term CRC survivors. Among Medicare beneficiaries, the use of claims data regarding PNM vaccination highlights the relatively poor utilization of guideline-directed preventive care.
影响因子：
12.7
作者：
Palmer NR;Geiger AM;Felder TM;Lu L;Case LD;Weaver KE
通讯作者：
Weaver KE
影响因子：
7.2
作者：
ROMANO, PS;ROOS, LL;JOLLIS, JG
通讯作者：
JOLLIS, JG